• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类HDAC4催化结构域的结构与功能分析揭示了一个具有调节作用的结构锌结合结构域。

Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain.

作者信息

Bottomley Matthew J, Lo Surdo Paola, Di Giovine Paolo, Cirillo Agostino, Scarpelli Rita, Ferrigno Federica, Jones Philip, Neddermann Petra, De Francesco Raffaele, Steinkühler Christian, Gallinari Paola, Carfí Andrea

机构信息

Istituto di Ricerche di Biologia Molecolare P. Angeletti, Merck Research Laboratories, Via Pontina Km 30.600, 00040 Pomezia (Roma), Italy.

出版信息

J Biol Chem. 2008 Sep 26;283(39):26694-704. doi: 10.1074/jbc.M803514200. Epub 2008 Jul 8.

DOI:10.1074/jbc.M803514200
PMID:18614528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3258910/
Abstract

Histone deacetylases (HDACs) regulate chromatin status and gene expression, and their inhibition is of significant therapeutic interest. To date, no biological substrate for class IIa HDACs has been identified, and only low activity on acetylated lysines has been demonstrated. Here, we describe inhibitor-bound and inhibitor-free structures of the histone deacetylase-4 catalytic domain (HDAC4cd) and of an HDAC4cd active site mutant with enhanced enzymatic activity toward acetylated lysines. The structures presented, coupled with activity data, provide the molecular basis for the intrinsically low enzymatic activity of class IIa HDACs toward acetylated lysines and reveal active site features that may guide the design of class-specific inhibitors. In addition, these structures reveal a conformationally flexible structural zinc-binding domain conserved in all class IIa enzymes. Importantly, either the mutation of residues coordinating the structural zinc ion or the binding of a class IIa selective inhibitor prevented the association of HDAC4 with the N-CoR.HDAC3 repressor complex. Together, these data suggest a key role of the structural zinc-binding domain in the regulation of class IIa HDAC functions.

摘要

组蛋白去乙酰化酶(HDACs)调节染色质状态和基因表达,对其进行抑制具有重要的治疗意义。迄今为止,尚未鉴定出IIa类HDACs的生物学底物,仅证明其对乙酰化赖氨酸具有低活性。在此,我们描述了组蛋白去乙酰化酶-4催化结构域(HDAC4cd)以及对乙酰化赖氨酸具有增强酶活性的HDAC4cd活性位点突变体的抑制剂结合和无抑制剂结构。所呈现的结构与活性数据相结合,为IIa类HDACs对乙酰化赖氨酸固有的低酶活性提供了分子基础,并揭示了可能指导设计类特异性抑制剂的活性位点特征。此外,这些结构揭示了在所有IIa类酶中保守的构象灵活的结构锌结合结构域。重要的是,协调结构锌离子的残基突变或IIa类选择性抑制剂的结合均阻止了HDAC4与N-CoR.HDAC3阻遏复合物的缔合。总之,这些数据表明结构锌结合结构域在IIa类HDAC功能调节中起关键作用。

相似文献

1
Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain.人类HDAC4催化结构域的结构与功能分析揭示了一个具有调节作用的结构锌结合结构域。
J Biol Chem. 2008 Sep 26;283(39):26694-704. doi: 10.1074/jbc.M803514200. Epub 2008 Jul 8.
2
Mutagenesis Study Reveals the Rim of Catalytic Entry Site of HDAC4 and -5 as the Major Binding Surface of SMRT Corepressor.诱变研究揭示HDAC4和HDAC5催化入口位点的边缘是SMRT共抑制因子的主要结合表面。
PLoS One. 2015 Jul 10;10(7):e0132680. doi: 10.1371/journal.pone.0132680. eCollection 2015.
3
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.解析脊椎动物IIa类组蛋白去乙酰化酶的潜在催化活性。
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17335-40. doi: 10.1073/pnas.0706487104. Epub 2007 Oct 23.
4
Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity.人类HDAC7含有一个IIa类组蛋白去乙酰化酶特异性锌结合基序和潜在的去乙酰化酶活性。
J Biol Chem. 2008 Apr 25;283(17):11355-63. doi: 10.1074/jbc.M707362200. Epub 2008 Feb 19.
5
Novel structural insights into class I and II histone deacetylases.对I类和II类组蛋白去乙酰化酶的新型结构见解。
Curr Top Med Chem. 2009;9(3):235-40. doi: 10.2174/156802609788085304.
6
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.人类HDAC8的结构快照为I类组蛋白去乙酰化酶提供了深入见解。
Structure. 2004 Jul;12(7):1325-34. doi: 10.1016/j.str.2004.04.012.
7
Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex.对IIa类组蛋白去乙酰化酶(HDACs)募集至SMRT/NCoR转录抑制复合物的见解。
J Biol Chem. 2015 Jul 17;290(29):18237-18244. doi: 10.1074/jbc.M115.661058. Epub 2015 Jun 8.
8
Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.鉴定锚蛋白重复序列蛋白ANKRA和RFXANK为IIa类组蛋白去乙酰化酶的新伴侣。
J Biol Chem. 2005 Aug 12;280(32):29117-27. doi: 10.1074/jbc.M500295200. Epub 2005 Jun 17.
9
Structural basis of the specific interaction of SMRT corepressor with histone deacetylase 4.SMRT 核心抑制因子与组蛋白去乙酰化酶 4 特异性相互作用的结构基础。
Nucleic Acids Res. 2018 Dec 14;46(22):11776-11788. doi: 10.1093/nar/gky926.
10
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.通过非螯合锌结合基团选择性抑制 IIa 类组蛋白去乙酰化酶。
Nat Chem Biol. 2013 May;9(5):319-25. doi: 10.1038/nchembio.1223. Epub 2013 Mar 24.

引用本文的文献

1
Class IIa HDACs Are Important Signal Transducers with Unclear Enzymatic Activities.IIa类组蛋白去乙酰化酶是具有不明酶活性的重要信号转导分子。
Biomolecules. 2025 Jul 22;15(8):1061. doi: 10.3390/biom15081061.
2
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function.一种潜在血液系统恶性肿瘤疗法的发现:靶向非酶功能的选择性强效组蛋白去乙酰化酶7(HDAC7)蛋白酶体靶向嵌合体降解剂
Acta Pharm Sin B. 2025 Mar;15(3):1659-1679. doi: 10.1016/j.apsb.2025.01.021. Epub 2025 Jan 30.
3
New potent N-hydroxycinnamamide-based histone deacetylase inhibitors suppress proliferation and trigger apoptosis in THP-1 leukaemia cells.新型强效N-羟基肉桂酰胺类组蛋白去乙酰化酶抑制剂可抑制THP-1白血病细胞增殖并引发凋亡。
Arch Pharm (Weinheim). 2025 Apr;358(4):e2400889. doi: 10.1002/ardp.202400889.
4
adenylate cyclase toxin elicits chromatin remodeling and transcriptional reprogramming that blocks differentiation of monocytes into macrophages.腺苷酸环化酶毒素引发染色质重塑和转录重编程,从而阻止单核细胞分化为巨噬细胞。
mBio. 2025 Apr 9;16(4):e0013825. doi: 10.1128/mbio.00138-25. Epub 2025 Mar 19.
5
Scaffolding Activities of Pseudodeacetylase HDAC7.假脱乙酰酶HDAC7的支架活性
ACS Chem Biol. 2025 Feb 21;20(2):248-258. doi: 10.1021/acschembio.4c00753. Epub 2025 Feb 5.
6
JRM-28, a Novel HDAC2 Inhibitor, Upregulates Plasticity-Associated Proteins in Hippocampal Neurons and Enhances Morphological Plasticity via Activation of CREB: Implications for Alzheimer's Disease.新型组蛋白去乙酰化酶2抑制剂JRM-28上调海马神经元中与可塑性相关的蛋白质,并通过激活CREB增强形态可塑性:对阿尔茨海默病的意义
Cells. 2024 Nov 27;13(23):1964. doi: 10.3390/cells13231964.
7
Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors.基于结构的新型组蛋白去乙酰化酶4(HDAC4)抑制剂的鉴定
Pharmaceuticals (Basel). 2024 Jul 2;17(7):867. doi: 10.3390/ph17070867.
8
miR-1 as a Key Epigenetic Regulator in Early Differentiation of Cardiac Sinoatrial Region.miR-1 作为心脏窦房结早期分化的关键表观遗传调控因子。
Int J Mol Sci. 2024 Jun 15;25(12):6608. doi: 10.3390/ijms25126608.
9
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods.组蛋白去乙酰化酶家族:结构特征及联合计算方法的应用
Pharmaceuticals (Basel). 2024 May 10;17(5):620. doi: 10.3390/ph17050620.
10
Roles of Histone Deacetylase 4 in the Inflammatory and Metabolic Processes.组蛋白去乙酰化酶 4 在炎症和代谢过程中的作用。
Diabetes Metab J. 2024 May;48(3):340-353. doi: 10.4093/dmj.2023.0174. Epub 2024 Mar 22.

本文引用的文献

1
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy.一种调节II类组蛋白去乙酰化酶和心肌肥大的氧化还原依赖性途径。
Cell. 2008 Jun 13;133(6):978-93. doi: 10.1016/j.cell.2008.04.041.
2
2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.2-三氟乙酰噻吩类化合物,一类新型的强效、选择性II类组蛋白去乙酰化酶抑制剂。
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3456-61. doi: 10.1016/j.bmcl.2008.02.026. Epub 2008 Feb 14.
3
Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity.人类HDAC7含有一个IIa类组蛋白去乙酰化酶特异性锌结合基序和潜在的去乙酰化酶活性。
J Biol Chem. 2008 Apr 25;283(17):11355-63. doi: 10.1074/jbc.M707362200. Epub 2008 Feb 19.
4
Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling.一氧化氮通过激活蛋白磷酸酶2A和II类组蛋白去乙酰化酶的核穿梭来调节人内皮细胞中的染色质折叠。
Circ Res. 2008 Jan 4;102(1):51-8. doi: 10.1161/CIRCRESAHA.107.157305. Epub 2007 Nov 1.
5
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.解析脊椎动物IIa类组蛋白去乙酰化酶的潜在催化活性。
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17335-40. doi: 10.1073/pnas.0706487104. Epub 2007 Oct 23.
6
Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex.如HDAC8-底物复合物的晶体结构所示,底物与组蛋白脱乙酰酶的结合。
EMBO Rep. 2007 Sep;8(9):879-84. doi: 10.1038/sj.embor.7401047. Epub 2007 Aug 10.
7
Class IIa histone deacetylases: regulating the regulators.IIa类组蛋白去乙酰化酶:调控调节因子
Oncogene. 2007 Aug 13;26(37):5450-67. doi: 10.1038/sj.onc.1210613.
8
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface.用于治疗心肌肥大的小分子疗法:深入细胞表面之下
Nat Rev Drug Discov. 2007 Aug;6(8):617-35. doi: 10.1038/nrd2193.
9
Complex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitor.细菌2类组蛋白去乙酰化酶同系物与三氟甲基酮抑制剂的复杂结构
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Apr 1;63(Pt 4):270-3. doi: 10.1107/S1744309107012377. Epub 2007 Mar 23.
10
Crystal structure of a conserved N-terminal domain of histone deacetylase 4 reveals functional insights into glutamine-rich domains.组蛋白去乙酰化酶4保守N端结构域的晶体结构揭示了对富含谷氨酰胺结构域的功能见解。
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4297-302. doi: 10.1073/pnas.0608041104. Epub 2007 Mar 5.